HRTXHeron Therapeutics, Inc.May 11, 2026Q1 2026
Read transcript →Heron Therapeutics, Inc. (HRTX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$0.50
+2.04%
Mkt Cap $72.49M
HRTXHeron Therapeutics, Inc.May 11, 2026HRTXHeron Therapeutics, Inc.Feb 26, 2026Q4 2025
Read transcript →HRTXHeron Therapeutics, Inc.Nov 4, 2025Q3 2025
Read transcript →HRTXHeron Therapeutics, Inc.Aug 8, 2025Q2 2025
Read transcript →HRTXHeron Therapeutics, Inc.May 6, 2025Q1 2025
Read transcript →HRTXHeron Therapeutics, Inc.Feb 27, 2025Q4 2024
Read transcript →HRTXHeron Therapeutics, Inc.Nov 12, 2024Q3 2024
Read transcript →HRTXHeron Therapeutics, Inc.Aug 9, 2024Q2 2024
Read transcript →HRTXHeron Therapeutics, Inc.May 7, 2024Q1 2024
Read transcript →HRTXHeron Therapeutics, Inc.Mar 12, 2024Q4 2023
Read transcript →HRTXHeron Therapeutics, Inc.Nov 14, 2023Q3 2023
Read transcript →HRTXHeron Therapeutics, Inc.Aug 14, 2023Q2 2023
Read transcript →HRTXHeron Therapeutics, Inc.May 11, 2023Q1 2023
Read transcript →HRTXHeron Therapeutics, Inc.Mar 23, 2023Q4 2022
Read transcript →HRTXHeron Therapeutics, Inc.Nov 8, 2022Q3 2022
Read transcript →HRTXHeron Therapeutics, Inc.Aug 9, 2022Q2 2022
Read transcript →HRTXHeron Therapeutics, Inc.May 9, 2022Q1 2022
Read transcript →HRTXHeron Therapeutics, Inc.Feb 28, 2022Q4 2021
Read transcript →HRTXHeron Therapeutics, Inc.Nov 3, 2021Q3 2021
Read transcript →